Showing results (191-200 of 222) with videos related to
Sort By:
Pageof 23
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2025
Structurally Oriented Classification of FOXA1 Alterations Identifies Prostate Cancers with Opposing Clinical Outcomes and Distinct Molecular and Immunologic SubtypesJustin Hwang, Pornlada Likasitwatanakul, Sachin Kumar Deshmukh, et al.Cancer Research Communications|May 6, 2024
Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human MalignanciesCarly D Miller, John R Lozada, Nicholas A Zorko, et al.Clinical Genitourinary Cancer|June 8, 2019
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials ConsortiumChanning J Paller, Emmanuel S Antonarakis, Tomasz M Beer, et al.Prostate Cancer and Prostatic Diseases|March 1, 2020
Survival of African-American and Caucasian men after sipuleucel-T immunotherapy: outcomes from the PROCEED registryOliver Sartor, Andrew J Armstrong, Chiledum Ahaghotu, et al.Biorxiv : the Preprint Server for Biology|November 1, 2024
Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome activation and sensitizes prostate cancer to immunotherapyAmber N Clements, Andrea L Casillas, Caitlyn E Flores, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 24, 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT TrialCharles B Nguyen, Melissa A Reimers, Chamila Perera, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2020
CD8+ T Cells Impact Rising PSA in Biochemically Relapsed Cancer Patients Using Immunotherapy Targeting Tumor-Associated AntigensNeal D Shore, Matthew P Morrow, Trevor McMullan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2017
Muscadine Grape Skin Extract (MPX) in Men with Biochemically Recurrent Prostate Cancer: A Randomized, Multicenter, Placebo-Controlled Clinical TrialChanning J Paller, Xian C Zhou, Elisabeth I Heath, et al.Cancer Immunology Research|February 21, 2025
Inhibition of PIM Kinase in Tumor-Associated Macrophages Suppresses Inflammasome Activation and Sensitizes Prostate Cancer to ImmunotherapyAmber N Clements, Andrea L Casillas, Caitlyn E Flores, et al.Prostate Cancer and Prostatic Diseases|February 28, 2024
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient OutcomesNicholas A Zorko, Allison Makovec, Andrew Elliott, et al.Pageof 23